Mesothelin expression as a predictive biomarker of breast cancer outcomes

被引：0
|
作者：
Li, Yun Rose
Xian, Rena R.
Ziober, Amy
Conejo-Garcia, Jose
June, Carl H.
Zhang, Paul J.
Tchou, Julia C.
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[3] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[4] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[5] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[6] Univ Penn Hlth Syst, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.11119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11119
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mesothelin expression is associated with poor outcomes in breast cancer
    Yun R. Li
    Rena R. Xian
    Amy Ziober
    Jose Conejo-Garcia
    Alfredo Perales-Puchalt
    Carl H. June
    Paul J. Zhang
    Julia Tchou
    Breast Cancer Research and Treatment, 2014, 147 : 675 - 684
  • [2] Mesothelin expression is associated with poor outcomes in breast cancer
    Li, Yun R.
    Xian, Rena R.
    Ziober, Amy
    Conejo-Garcia, Jose
    Perales-Puchalt, Alfredo
    June, Carl H.
    Zhang, Paul J.
    Tchou, Julia
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (03) : 675 - 684
  • [3] Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer
    Parinyanitikul, Napa
    Blumenschein, George R.
    Wu, Yun
    Lei, Xiudong
    Chavez-MacGregor, Mariana
    Smart, Melody
    Gonzalez-Angulo, Ana Maria
    CLINICAL BREAST CANCER, 2013, 13 (05) : 378 - 384
  • [4] Mesothelin expression and survival outcomes in triple-receptor negative breast cancer.
    Parinyanitikul, Napa
    Blumenschein, George R.
    Wu, Yun
    Lei, Xiudong
    Gregor, Mariana Chavez-Mac
    Smart, Melody L.
    Gonzalez-Angulo, Ana M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Clinicopathological Significance of Mesothelin Expression in Invasive Breast Cancer
    Wang, L.
    Niu, Z.
    Zhang, L.
    Liu, X.
    Wang, X.
    Li, F.
    Wang, Y.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (03) : 909 - 916
  • [6] RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
    Engebraaten, Olav
    Yau, Christina
    Berg, Kristian
    Borgen, Elin
    Garred, Oystein
    Berstad, Maria E. B.
    Fremstedal, Ane S., V
    De Michele, Angela
    van't Veer, Laura
    Esserman, Laura
    Weyergang, Anette
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [7] RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
    Olav Engebraaten
    Christina Yau
    Kristian Berg
    Elin Borgen
    Øystein Garred
    Maria E. B. Berstad
    Ane S. V. Fremstedal
    Angela DeMichele
    Laura van ’t Veer
    Laura Esserman
    Anette Weyergang
    Nature Communications, 12
  • [8] BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer
    Liao, Muheng
    Webster, Jace
    Coonrod, Emily M.
    Weilbaecher, Katherine N.
    Maher, Christopher A.
    White, Nicole M.
    CLINICAL BREAST CANCER, 2024, 24 (04) : 368 - 375.e2
  • [9] Qualifying an IHC Predictive Biomarker-Her2 Low Expression in Breast Cancer
    Morgan, S. R.
    Ellis, I. O.
    Warren, M. V.
    Womack, C.
    JOURNAL OF PATHOLOGY, 2013, 231 : 31 - 31
  • [10] Expression profiling of circulating tumor cells: A prognostic and predictive biomarker in metastatic breast cancer
    Bredemeier, Maren
    Kubista, Mikael
    Sjoeback, Robert
    Jendrichova, Marie
    Rohlova, Eva
    Novosadova, Vednula
    Kolostova, Katarina
    Hauch, Siegfried
    Aktas, Bahriye
    Tewes, Mitra
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    CANCER RESEARCH, 2015, 75
12345